Pac in Medical Technology

Research Shows Decas Sweetened Dried Cranberries Pack Twice the Proanthocyanidin Punch as Cranberry Juice Cocktail

...have high antioxidant activity and a unique A-type pac linkage structure that sets it apart from most other plants. "Brunswick Labs' data on the pac content of SDCs shows levels much higher than orig...earch updates older information about the relative pac levels found in SDCs and cranberry juice cocktail....

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

... A conference call to review results will be held on August 4, 2009 at 2 PM pacific Time. Details are below: Howard Robin, president and c...l host a conference call beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. pacific Time (PT) on Tuesday, August 4, 2009. To access the co...

Scientists Discover Origin of Malaria

...ccurs primarily in tropical and subtropical regions such as Central and South America, Southeast Asia, sub-Saharan Africa, the Caribbean and the South pacific Islands. The Global Viral Forecasting Initiative has spent the last ten years developing a global system to prevent pandemics. By ...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

...day cycles, with cohort one receiving 135 mg/m2 of paclitaxel poliglumex and 500 mg/m2 of pemetrexed, and cohort two receiving 175 mg/m2 of paclitaxel poliglumex and 500 mg/m2 of pemetrexed. No...biologically enhanced, chemotherapeutic that links paclitaxel, the active ingredient in Taxol(R), to a b...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

...ic output. The current proposed "Pathways to Biosimilars Act" now before Congress paves the way for innovation by allowing for a 14-year data package exclusivity period for Lilly to recoup its investment. Is it too much to ask to be able to protect the recipe for a billion-dollar investment to ...

July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals

...ys. Don't crowd. A refrigerator that is too full blocks air circulation, hampering the cooling process. Know when to toss. An opened package of luncheon meat can be safely stored in the refrigerator three to five days. Unopened, it will keep for two weeks. Three to five days is a safe ...

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

... and supply issues. The potential for exenatide once weekly may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the development and commercialization of pharmaceutical produ...

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

...ctivity in 7 of 9 NSCLC cell lines examined. The combinations demonstrated strong synergistic effects on cell killing. The combination of reovirus and paclitaxel was invariably synergistic in all cell lines tested, regardless of their level of sensitivity to either agent. The investigators concluded t...

Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks

...- has developed mechanisms to eliminate antibiotics once they have entered the cell. Fluidosomes(TM)-tobramycin seems to overcome these limitations by packing tobramycin into liposomes, which, by allowing effective penetration of the antibiotic into the bacterial cell, completely changes the microbiolog...

ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients

...rter 2009 10-Q, filed May 1, 2009. References: 1. ASMANEX (R) package Insert. Schering-Plough K.K. 2. ASMANEX (R) U.S. package Insert. Schering Corporation. ...

Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets

...ll rights, including rights of copying, distribution and republication. ** IMS national prescription data from 1992-July 2006. (1) Asacol HD package Insert (April 2009) (2) Hanauer SB et al. Am J Gastroenterol 2005; 100: 2478-2485. ...

deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia

...ved in brain development. Five of the SNPs are located very closely together in the Major Histocompatibility Complex, a region on chromosome 6 densely packed with genes regulating immune response. This lends support to previous research suggesting a possible environmental link between schizophrenia immu...

PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies

... nebulizer and PARI PRONEB Ultra compressor were used exclusively in pivotal clinical trials for Perforomist Inhalation Solution and are listed in the package insert. About PARI Respiratory Equipment, Inc. PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol deli...

Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases

... functionally equivalent to creating a lesion on the brain, but with the advantage of being adjustable and reversible. "It is like implanting a pacemaker for the brain," says Dr. Lee. The patient is awake during deep brain stimulation surgery while a neurosurgeon implants the electrodes. Patients...

SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts

...; 28th Street, New York, NY. Pre-registration is required via http://www.conference.youthsportsny.org The SUNY Youth Sports Institute will package evidence-based findings into one easy-to-understand, comprehensive program and make it available to medical practitioners, parents, educators, yo...

Hand Washing with 4% CHG Antiseptic Kills Flu Viruses

...sonnel Hand Antiseptic Towelettes have been tested and found to be effective against a variation of the A H1N1 Swine Flu Virus, when used according to package instructions. The strain tested was Swine Flu Influenza A H1N1 A/Swine/Iowa/15/3. The time-kill study, conducted by an independent labora...

Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies

... Covance's clinical development services include Phase I-IV clinical trial support in more than 55 countries, including emerging markets across Asia pacific, Central and Eastern Europe, and Latin America. About Covance Covance, with headquarters in Princeton, New Jersey, is one of the world'...

HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens

...verall healthcare costs, the Healthcare Compliance packaging Council (HCPC) noted that far greater savin...ces concludes, however, that better pharmaceutical packaging can significantly increase pharmaceutical c... for high blood pressure in two different types of packaging: one group received their drugs in standar...

Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health (CDRH)

...g ad-hoc methodologies with a reliable and easily-learned standard software package for both trial sponsors and regulators. Gerry W. Gray, Ph.D., is ...e not available in any validated, commercially viable, easy to use software package. Thus, execution of Bayesian clinical trials requires considerable exp...

Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th

...dditional Clinical Studies Also Highlighted at Pan pacific Conference Randomized ph...X 301 EXTEND trial") is being presented at the Pan pacific Lymphoma conference by Dr. Richard Van der Ja...sive first-line therapy with CHOP-R. The Pan pacific Lymphoma Conference poster is available at h...

Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs

...nd fully funded by Families of SMA. The next step for this program is to request a pre-IND meeting with the FDA and to prepare the required data package. Families of SMA will be working over the next several months with toxicology and regulatory experts to prepare for this meeting. According to Ji...

New Bisphenol A Study Is of Very Limited Relevance to Human Health

...dence, the consensus of regulatory agencies in the United States, Canada, Europe, and Japan is that the current levels of exposure to BPA through food packaging do not pose an immediate health risk to the general population, including infants and young children.'" www.americanchemistry.com ...

When It Comes to Natural Remedies for Hormonal Balance, the Proof Is in the Clinical Research

...er the manufacturing and distribution of its products. All NHI products are packaged in oxygen-barrier blister packs, recycled light-proof cardboard boxes, and are printed with vegetable in...

Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009

...r manufacturing and supply issues. The potential for BYETTA may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the commercialization of pharmaceutical products. These and a...

Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery

...ble as part of the upgradeable Masimo Rainbow SET(R) Pulse CO-Oximetry platform. (1) Bernard AC et al. Intraoperative transfusion of 1U to 2U of packed red blood cells is associated with increased 30-day mortality, surgical site infection, pneumonia, and sepsis in general surgery patients. Journa...

Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual

...the data to support FDA approval of the Delcath PHP System(TM). Our effort to expand the trial to leading cancer centers has produced the accelerated pace that delivers this milestone just months after hitting 50% accrual and we look forward to completing enrollment this year. The clinical data for the...

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

...sues. The potential for BYETTA and/or exenatide once weekly may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the development and commercialization of pharmaceutical produ...

Heaviest Smokers Face Greatest Risk of Death After Lung Cancer Diagnosis

...isease will progress. Patients who smoked two packs a day had a 58 percent higher risk of their lun...ime of diagnosis. Patients who smoked more than 61 packs a year had the greatest risk of their cancers r...ur study showed that those who smoked more than 61 packs a year are more likely to develop tumor recurre...

Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students

... medicine of lupus and bring down barriers that have impeded progress in research on the disease. In the past, medical research on lupus has not kept pace with efforts for other similar chronic and life-threatening diseases. The FDA has not approved a drug for lupus in 50 years. The five 2009 Gin...

Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials

...tuximab in Combination with Carboplatin and paclitaxel In the Phase II trial evaluating ba...tuximab in combination with carboplatin and paclitaxel in non-small cell lung cancer (NSCLC) ...tuximab in Combination with Carboplatin and paclitaxel In the Phase II trial evaluating ba...

Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer

...") rate when given OPAXIO, a biologically enhanced paclitaxel, in addition to cisplatin and full-course ...al studies have demonstrated that, unlike standard paclitaxel and other chemotherapeutic agents that enh... no evidence of distant metastasis received weekly paclitaxel poliglumex (50mg/m2) and cisplatin 25mg/m2...

TNFerade(TM) Phase III Data Presented at ASCO

...eported on results of an interim analysis from the pacT trial. This interim analysis of overall surviva...mp; Data" then "Data Presentations." About pacT GenVec's pac T trial is a multi-center, randomized, active, and...

Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

...d with 5-FU (another type of chemotherapy). GEMZAR in combination with paclitaxel is approved by the FDA for the first-line treatment of patients wit...t is to develop a broad portfolio of tailored therapies that accelerate the pace and progress of cancer care. To learn more about Lilly's commitment to c...

New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer

...ting neratinib safety and efficacy when given with paclitaxel (Taxol(R), Bristol-Myers Squibb) in patien...fficacy of Neratinib (HKI-272) in Combination with paclitaxel in Patients with Solid Tumors In a..., 240 mg) were administered in combination with IV paclitaxel 80 mg/m2, if tolerable, or 70 mg/m2 on day...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

...progress and is pushing it forward at what will be an extraordinarily quick pace. The Dream Teams bring together leading laboratory scientists and physici...ve The Stand Up To Cancer (SU2C) movement raises funds to hasten the pace of groundbreaking translational research that can get new therapies to pa...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

...reditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx ). ViroPharma currently focuses its drug development activities in diseases including cyt...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

...hat percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(R) paclitaxel-Eluting Coronary Stent System was consistently associated with fewe...ed, controlled clinical trial to compare PCI using the TAXUS(R) Express2(R) paclitaxel-Eluting Coronary Stent System to CABG surgery in patients with left...

Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma

...s. Newly diagnosed patients with Stage IIIB/IV NSCLC will be randomly assigned (1:1) to receive standard first-line chemotherapy with carboplatin and paclitaxel plus either oral talactoferrin or placebo. Agennix has received Fast Track designation from the FDA for both NSCLC indications as well as fav...

Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent

...unch of the platinum chromium TAXUS(R) Element(TM) paclitaxel-Eluting Coronary Stent System in select ma...nt series consists of three distinct versions: the paclitaxel-Eluting TAXUS Element Stent, the Everolimu...s, giving them the option to treat patients with a paclitaxel, everolimus or bare-metal stent. In my ex...

Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data

...that it has reached key milestones in bringing the paccocath(R) Technology closer to market as an option...re-occlude within a year after treatment. The paccocath technology is a proprietary drug matrix app...rea. Clinical results to date show that using the paccocath technology during an angioplasty procedure ...